[EN] ARYL HYDROCARBON RECEPTOR MODULATORS AND USES THEREOF<br/>[FR] MODULATEURS DU RÉCEPTEUR D'HYDROCARBURE ARYLE ET UTILISATIONS ASSOCIÉES
申请人:BETH ISRAEL DEACONESS MEDICAL CT INC
公开号:WO2019195682A1
公开(公告)日:2019-10-10
Provided are compounds of Formula (I), and pharmaceutically acceptable salts, solvates, hydrates, stereoisomers, tautomers, isotopically labeled derivatives, polymorphs, and prodrugs thereof, wherein X1-X4, RX, RC, RB, n, and Ring A are as defined herein. The compounds may be aryl hydrocarbon receptor agonists or partial aryl hydrocarbon receptor agonists. Also provided are pharmaceutical compositions comprising a compound of Formula (I) and methods of using such compounds for treating diseases and conditions related to the activity of an aryl hydrocarbon receptor, such as, for example, inflammatory diseases, autoimmune diseases, metabolic disorders, and proliferative diseases.
提供了公式(I)的化合物,以及其药学上可接受的盐,溶剂合物,水合物,立体异构体,互变异构体,同位素标记衍生物,多晶形式和前药,其中X1-X4,RX,RC,RB,n和环A的定义如本文所述。这些化合物可以是芳香族碳氢化合物受体激动剂或部分芳香族碳氢化合物受体激动剂。还提供了包含公式(I)化合物的药物组合物以及使用这些化合物治疗与芳香族碳氢化合物受体活性相关的疾病和病况的方法,例如炎症性疾病,自身免疫性疾病,代谢紊乱和增生性疾病。